Related Experiment Video
Updated: Jul 3, 2026

10:35
Microvascular Decompression: Salient Surgical Principles and Technical Nuances
Published on: July 5, 2011
[Microvascular descompression for trigeminal neuralgia: prognostic [corrected] factors]
F Alberione1, A Arena, R Matera
1Hospital Británico, Sanatorio Agote, Clínica Sagrada Familia, Buenos Aires, Argentina.
Summary
Microvascular decompression (MVD) offers excellent outcomes for trigeminal neuralgia. Factors like female sex and longer neuralgia duration predict poorer results, suggesting alternative treatments may be needed.
Area of Science:
- Neurosurgery
- Neurology
- Medical research
Context:
- Trigeminal neuralgia is a debilitating condition affecting facial nerves.
- Microvascular decompression (MVD) is a surgical treatment option.
- Identifying prognostic factors for MVD outcomes is crucial for patient management.
Purpose:
- To evaluate the effectiveness of Microvascular Decompression (MVD) for typical trigeminal neuralgia.
- To identify prognostic factors influencing MVD outcomes in trigeminal neuralgia patients.
Summary:
- A retrospective study of 89 trigeminal neuralgia patients undergoing MVD between 1995-2005 was conducted.
- Excellent outcomes were observed in 77% of patients one year post-surgery.
- Poor outcomes were associated with female sex, neuralgia duration over two years, involvement of all three trigeminal divisions, venous compression, and the use of muscle grafts.
Impact:
- Microvascular decompression is confirmed as an effective and reliable treatment for trigeminal neuralgia.
- The use of muscle grafts during MVD is not recommended.
- Alternative surgical techniques should be considered when all three trigeminal divisions are affected.